Skip to content
No picture yet

Brilinta 60 mg – DIN 02455005

Brilinta is Ticagrelor 60 mg (tablet), sold in Canada. It is supplied by Astrazeneca Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Ticagrelor 60 mg

Brand
Brilinta
Strength
60 mg
Form
Tablet
Manufacturer
Astrazeneca Canada Inc
Drug class
Antiplatelet medicine (prevents clots)
Sold in
Canada
DIN
02455005

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ticagrelor pills and guides

What is Ticagrelor used for?

Ticagrelor is an antiplatelet medicine (prevents clots).

Medicine type
Antiplatelet medicine (prevents clots)
Official uses from the US prescribing label

Acute Coronary Syndrome or a History of Myocardial Infarction

Ticagrelor tablets are indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel.

Ticagrelor tablet also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS.

Coronary Artery Disease but No Prior Stroke or Myocardial Infarction

Ticagrelor tablet is indicated to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events. While use is not limited to this setting, the efficacy of ticagrelor tablet was established in a population with type 2 diabetes mellitus (T2DM).

Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

Ticagrelor tablet is indicated to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score ≤5) or high-risk transient ischemic attack (TIA).

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02455005.
  • It names Brilinta, Ticagrelor 60 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Brilinta by Astrazeneca Canada Inc.

In Canada: prescription only.

Ingredients

Active: Ticagrelor

Other Ticagrelor pills